undamentalytics Newsletter
Sign in

Albemarle Corporation income statement

In fiscal 2025, Albemarle Corporation reported revenue of $5.14bn, down 4.4% on the year before, operating income of −$367m (a -7.1% margin) and net income of −$511m, or −$5.76 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2,0052,3632,8692,5192,3942,4462,8262,6773,0723,3753,5893,1293,3287,3209,6175,3785,1435,908
Cost of revenue———————1,7071,9662,1582,3322,1342,3304,2468,4315,3154,4744,501
Gross profit4847429558998507718609701,1061,2171,2589959983,0751,186636691,407
Research and development615877798288898084705859547286875138
Selling, general and administrative213275360308158355300354450446533430441524910618550558
Operating income1864025184005772713456015729126665067982,470252−1,777−367252
Income before tax2575277126615345393115154477955633741342,433247−1,764−552172
Income tax−7881048013418119643214588542939143087157242
Net income178316392312413133335644556945333761242,6901,573−1,179−511224
Diluted EPS$1.94$3.43$4.28$3.47$4.90$1.69$3.00$5.68$0.49$6.34$5.02$3.52$1.06$22.84$13.36−$11.20−$5.76$1.83
Diluted shares (average)92m92m92m90m84m79m112m113m112m109m106m107m117m118m118m118m118m123m
EBITDA2874986154996843756058277691,1128807381,0522,771682−1,188292894

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ALB vs AXTAALB vs RPMALB vs CBT

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Albemarle Corporation's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Albemarle Corporation.